Journal Article DKFZ-2022-01892

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Anaplastic ganglioglioma - a diagnosis comprising several distinct tumour types.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2022
Wiley-Blackwell Oxford [u.a.]

Neuropathology & applied neurobiology 48(7), e12847 () [10.1111/nan.12847]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Anaplastic ganglioglioma is a rare tumour and diagnosis has been based on histological criteria. The 5th edition of the World Health Organization Classification of Tumours of the Central Nervous System (CNS WHO) does not list anaplastic ganglioglioma as a distinct diagnosis due to lack of molecular data in previous publications AIM: We retrospectively compiled a cohort of 54 histologically diagnosed anaplastic gangliogliomas to explore whether the molecular profiles of these tumours represent a separate type or resolve into other entities METHODS: Samples were subjected to histological review, DNA methylation profiling and next generation sequencing. Morphologic and molecular data were summarised to an integrated diagnosis RESULTS: The majority of histologically diagnosed anaplastic gangliogliomas resolved into CNS WHO diagnoses of glial tumours, most commonly pleomorphic xanthoastrocytoma (16/54), glioblastoma, IDH wildtype and diffuse paediatric-type high-grade glioma, H3 wildtype and IDH wildtype (11 and 2/54) followed by low-grade glial or glioneuronal tumours including pilocytic astrocytoma, dysembryoplastic neuroepithelial tumour and diffuse leptomeningeal glioneuronal tumour (5/54), IDH mutant astrocytoma (4/54) and others (6/54). A subset of tumours (10/54) was not assignable to a CNS WHO diagnosis and common molecular profiles pointing to a separate entity were not evident CONCLUSION: In summary, we show that tumours histologically diagnosed as anaplastic ganglioglioma comprise a wide spectrum of CNS WHO tumour types with different prognostic and therapeutic implications. We therefore suggest assigning this designation with caution and recommend comprehensive molecular workup.

Keyword(s): DNA methylation analysis ; anaplastic ganglioglioma ; ganglioglioma ; methylation class ; molecular glioma entities ; molecular neuropathology

Classification:

Note: #EA:B300#LA:B300# / 2022 Dec;48(7):e12847

Contributing Institute(s):
  1. KKE Neuropathologie (B300)
  2. DKTK BE zentral (BE01)
  3. DKTK HD zentral (HD01)
  4. DKTK ED ES zentral (ED01)
  5. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
  6. B062 Pädiatrische Neuroonkologie (B062)
  7. KKE Neuroonkologie (B320)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2022
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > D170
Public records
Publications database

 Record created 2022-08-18, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)